VESGEN 3D as Innovative Research & Discovery Tool for advances in: 1) Astronaut health countermeasures for established risks such as Visual Impairments Associated with Increased Intraocular Pressure (VIIP). 2) Improved understanding for better targeting of vascular therapies for diabetic retinopathy and cancer. Grant and Project funding by NASA Life Sciences, ExMC HRP, NIH. Licensing by imaging and drug development companies. Rotational 3D geometry in more complex organs. Potential customers and Applications: NASA Space Life Sciences (ISS and beyond); ExMC HRP; Space Radiation; US National Institutes of Health; Imaging Companies (Zeiss, Optovue, Heidelberg Engineering); Drug Discovery Companies (Genentech, Pfizer)
More »